<DOC>
	<DOCNO>NCT00991458</DOCNO>
	<brief_summary>This study evaluate safety efficacy Cyclosporine 0.005 % 0.010 % eye drop administer twice daily follow LASIK surgery .</brief_summary>
	<brief_title>Study Cyclosporine Post-LASIK Patients</brief_title>
	<detailed_description />
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patient schedule bilateral LASIK surgery Patient good general health Eye glass prescription 1 8 Significant Dry Eye Presence eye disease Uncontrolled systemic disease Previous use RESTASISÂ®</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>